In recent decades, the need for early, prolonged and individual rehabilitation to meet the needs of each patient suffering from stroke has become increasingly pronounced. On the one hand, this necessity is due to the fact that stroke has been shown to have high levels of morbidity, sickness and mortality. Therefore, it is defined as a burden for patients and their families. On the other hand, population aging requires a search for effective, efficient and acceptable models to address the problems of these patients. Globally, dozens of communities face different barriers to accessing health services. In response, numerous initiatives are aimed at promoting technological innovation, new management approaches and health policies. The rapid development and introduction of laboratory innovations suggest that tests should be carried out by the patient in a home environment, increasing the timeliness of medical and health care. New laboratory capabilities are the key to a new, integrated model that will ensure the timeliness of the required laboratory results to promote good self-control of the disease and the precision in providing rehabilitation care to patients suffering from stroke.
Бончева, М., Цолова Г., Димова Р., Метаболитният синдром – познания на общопрактикуващите лекари по проблема у нас, Социална медицина, бр.3, 2006.
Бончева M., Радкова М., Данева Д., Оценка на възпалението и липидния статус при пациенти с исхимична болест на сърцето и последваща коронарография, Варненски медицински форум, т.2,приложение 3, 217 – 220, 2013.
Национална здравна стратегия 2014-2020 Available from: https://www.mh.government.bg/media/filer_public/2015/04/08/nacionalna-zdravna-strategia_2014-2020.pdf/ 06.02.2019.
Национална стратегия за хроничните болести, 2014 – 2020.
Недев Н., Персоналният подход в рехабилитационните грижи – необходимо условие за повишаване на качеството на живот при пациенти с мозъчен инсулт, Варненски медицински форум, т. 5, 2016, приложение 3, 202-205
Недев Н., Г. Ненова, П. Манчева, Здравни грижи за пациентите с мозъчен инсулт – предизвикателство за рехабилитацията в домашни условия, Варненски медицински форум, т.5, 2016, приложение 3, 158-161
Недев Н., П. Манчева, Н. Негрев, С. Филкова, Необходимост от провеждане на продължителна рехабилитация при пациенти, преживели мозъчен инсулт, Варненски медицински форум, т.3, 2014, 49-52
Недев Н., П. Манчева, Н. Негрев, Оценка на удовлетвореността от проведената рехабилитация на пациенти, преживели мозъчен инсулт, Варненски медицински форум, т.4, 2015, 153-157
Постаджиян А., Цончева А., Койчева Н., Финков Б., Прогностично значение на тропонин Т и С-реактивен протеин при болни с остри коронарни синдроми без ST сегмент елевация. Българска Кардиология, 3, 149–157, 2006.
Постаджиян А., Цончева А., Тропонин Т и 30 дневен риск от сърдечни усложнения при пациенти с остър коронарен синдром без ST сегмент елевация. Обща Медицина, том 2, 15–21, 2007.
Batista MV. Generalidades sobre AVC no adulto jovem. Revista Sinapse. 2012(1): 206
Bereznicki LR, Jackson SL, Peterson GM. Supervised patient self-testing of warfarin therapy using an online system. Jmed Internet Res;15;(7): e138, 2013.
Deledda John M, Fermann G, Lindsell Ch. et all. Cardiav Point-of-Care Testing: Impact on Emergency Department Door to Disposition Time is Modified by Patient Acuity and Hospital Setting. Point of Care: The Journal of Near-Patient Testing and Technology. March 2011, 10 (1), 1-6.
Du Y, Zhang W, Wang ML, An On-Chip Disposable Salivary Glucose Sensor for Diabetes Control. J Diabetes Sci Technol. 2016 Nov 1; 10(6):1344-1352.
Eckel RH, Grungy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005, 365, 1415-1428.
Ghosh J, Sil PC. Arjunolic acid: a new multifunctional therapeutic promise of alternative medicine. Biochimie. 2013 Jun; 95(6):1098-109.
Gilbert H., Szokol J., Point of care
technologies, Advances in Bedside Monitoring and Analysis: 2003, 73-92.
Goble JA, Rocafort PT2. Point-of-Care Testing: Future of Chronic Disease State Management? J Pharm Pract. 2015 PMID:26092752 [PubMed]
Kim JS, Oh HB, Kim AH, Kim JS, Lee ES, Baek JY, Lee KS, Chung SC, Jun JH. A study on detection of glucose concentration using changes in color coordinates. Bioengineered. 2017 Jan 2;8 (1):99-104.
Krouwer J, Why the New FDA Glucose Meter POCT Guidance Is Disappointing, J Diabetes Sci Technol., 2016PMID: 27923882. [PubMed]
Kwon HJ, Lee J, Park HI, Han K, Evaluation of a novel point-of-care test kit, ABSOGENâ„¢ PCT, in semi-quantitative measurement of procalcitonin in whole blood. J Clin Lab Anal. 2016 Dec 13. [PubMed]
Lee-Lewandrowski E, Laposata M, Eschenbach K, et al. Utilization and cost analysis of bedside capillary glucose testing in a large teaching hospital: implications for managing point of care testing. Am J Med. 2002, 97, 222-230. 96.
Point-of care testing guidelines.Washington State Clinical Laboratory Advisory Council. Originally published: October 2000. Reviewed/Revised: March 2005/March 2009.
Price, Point of care testing Clinical review; 2004, (322), 1285-1289.
Ribet F, Stemme G, Roxhed N, Ultra-miniaturization of a planar amperometric sensor targeting continuous intradermal glucose monitoring. Biosens Bioelectron. 2017 Apr 15; 90: 577-583.
Richter C, Taylor J, Wright J, Fletcher B, Clinical Validation of R-T Estimation for CoaguChek XS INR Results. Ann Pharmacother. 2016 Aug; 50(8):645-8.
Weig BH, Neogi T, McGuire H. Point-of-care diagnostics in low-resource settings and their impact on care in the age of the non-communicable and chronic disease epidemic. J Lab Autom.2014;19(3):248-257.
WHO, Global status report on noncommunicable diseases 2014, ISBN: 978 92 4 156485 4
www.dexcom.com/compatibility
www.pointofcaresearch.com
www.chrono-bg.com.
